| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 236,00 | 237,70 | 17:12 | |
| 236,00 | 237,70 | 17:12 |
Das US-amerikanische Biotechnologieunternehmen ist ein neuer Stern in der Biotech-Branche. Die Alnylam-Aktie machte in den letzten beiden Monaten einen Kurssprung von beeindruckenden +100%.Den vollständigen Artikel lesen ...| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | This Is What Whales Are Betting On Alnylam Pharmaceuticals | ||
| Di | Jefferies Taps Former Alnylam CEO Maraganore as Senior Adviser | ||
| Mo | ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study | ||
| Mo | Intellia's CRISPR and Alnylam's RNAi data drops present contrasting visions for cardiomyopathy care | ||
| So | Alnylam Presents New Phase 1 Results For Next-Gen RNAi Therapy Nucresiran In ATTR Amyloidosis | WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) has shared new findings from its Phase 1 study of nucresiran (previously known as ALN-TTRsc04), a next-generation RNAi therapy being... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 237,00 | +0,38 % |
